Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

Medizin & Biologie

• Brazil 6%
• Breast 5%
• Breast Neoplasms 9%
• Bulgaria 10%
• Canada 13%
• Centers for Disease Control and Prevention (U.S.) 7%
• Cervix Uteri 7%
• Child 3%
• Colonic Neoplasms 20%
• Data Analysis 94%
• Delivery of Health Care 4%
• Developed Countries 7%
• Early Diagnosis 6%
• Ecuador 10%
• Health Care Quality Indicators 11%
• Health Policy 7%
• Japan 12%
• Leukemia 12%
• Liver 3%
• Liver Neoplasms 7%
• Lung 3%
• Lung Neoplasms 5%
• Mongolia 11%
• Mortality 3%
• Neoplasms 40%
• New South Wales 9%
• North America 7%
• Northern Ireland 10%
• Ovarian Neoplasms 6%
• Ovary 6%
• Population 49%
• Precursor Cell Lymphoblastic Leukemia-Lymphoma 7%
• Prostate 6%
• Prostatic Neoplasms 5%
• Puerto Rico 9%
• Quality Control 7%
• Rectal Neoplasms 15%
• Rectum 7%
• Registries 100%
• Republic of Korea 17%
• Research Personnel 5%
• South America 9%
• Stomach Neoplasms 12%
• Survival 70%
• Survival Analysis 7%
• Switzerland 16%
• Thailand 16%
• Therapeutics 1%
• Uterine Cervical Neoplasms 6%
• Weights and Measures 4%